Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
This page covers the main factors that move indices, including earnings, policy, and macro conditions, with tips for interpreting changes.
28,658 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
As markets wobble in 2026, five stalwarts stand out for reliable income and resilience. Here are the safest dividend ...
Retail traders surged through May and June 2026, lifting volumes and reshaping daily moves. Five charts reveal how ch...
A cooler June CPI print sparked a risk-on bid in semiconductors, with AMD surging and Intel climbing as investors bet...
If you want growth exposure without buying dozens of stocks, the Vanguard Growth ETF (VUG) could be a fit. This guide...
GE Vernova surprised investors with strong momentum in the first half of 2026. This article breaks down what powered ...
NVIDIA's latest signals from Jensen Huang hint that AI chip demand remains robust. This article breaks down what that...
Investors weighing risk and return should consider meta platforms might good as a long-term hold. This guide breaks d...
The latest CPI data shows inflation moving in a way it hasn’t in years. This could shift Fed policy and rock the stoc...
MeridianLink unveils MeridianLink Intelligence within its MeridianLink One platform, introducing the Millie AI agent ...
NRMLA president Steve Irwin outlines a tougher operating climate for reverse mortgage lenders in 2026, even as tech a...
A growing cadre of investors is exploring whether a Tesla-SpaceX merger could become a true berkshire hathaway inside...